Effect of Salt Substitution on Cardiovascular Events and Death
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Salt substitutes with reduced sodium levels and increased potassium levels have been shown to lower blood pressure, but their effects on cardiovascular and safety outcomes are uncertain. METHODS: We conducted an open-label, cluster-randomized trial involving persons from 600 villages in rural China. The participants had a history of stroke or were 60 years of age or older and had high blood pressure. The villages were randomly assigned in a 1:1 ratio to the intervention group, in which the participants used a salt substitute (75% sodium chloride and 25% potassium chloride by mass), or to the control group, in which the participants continued to use regular salt (100% sodium chloride). The primary outcome was stroke, the secondary outcomes were major adverse cardiovascular events and death from any cause, and the safety outcome was clinical hyperkalemia. RESULTS: A total of 20,995 persons were enrolled in the trial. The mean age of the participants was 65.4 years, and 49.5% were female, 72.6% had a history of stroke, and 88.4% a history of hypertension. The mean duration of follow-up was 4.74 years. The rate of stroke was lower with the salt substitute than with regular salt (29.14 events vs. 33.65 events per 1000 person-years; rate ratio, 0.86; 95% confidence interval [CI], 0.77 to 0.96; P = 0.006), as were the rates of major cardiovascular events (49.09 events vs. 56.29 events per 1000 person-years; rate ratio, 0.87; 95% CI, 0.80 to 0.94; P<0.001) and death (39.28 events vs. 44.61 events per 1000 person-years; rate ratio, 0.88; 95% CI, 0.82 to 0.95; P<0.001). The rate of serious adverse events attributed to hyperkalemia was not significantly higher with the salt substitute than with regular salt (3.35 events vs. 3.30 events per 1000 person-years; rate ratio, 1.04; 95% CI, 0.80 to 1.37; P = 0.76). CONCLUSIONS: Among persons who had a history of stroke or were 60 years of age or older and had high blood pressure, the rates of stroke, major cardiovascular events, and death from any cause were lower with the salt substitute than with regular salt. (Funded by the National Health and Medical Research Council of Australia; SSaSS ClinicalTrials.gov number, NCT02092090.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, salt substitution with reduced sodium levels and increased potassium levels has been shown to reduce stroke, CVD, and overall mortality in patients with high CV risk.96”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Self-citationSacco, R. L., Kasner, S. E., Broderick, J. P., Caplan, L. R., Connors, J. J. (., Culebras, A., Elkind, M. S. V., George, M. G., Hamdan, A. D., Higashida, R. T., et al. (2013) · Stroke · doi:10.1161/str.0b013e318296aeca · Cited by 3,569
Effect of lower sodium intake on health: systematic review and meta-analyses
Aburto, N. J., Ziolkovska, A., Hooper, L., Elliott, P., Cappuccio, F. P., & Meerpohl, J. J. (2013) · BMJ · doi:10.1136/bmj.f1326 · Cited by 1,242
Self-citationSalt intakes around the world: implications for public health
Brown, I. J., Tzoulaki, I., Candeias, V., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp139 · Cited by 1,173
Self-citationAburto, N. J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P., & Cappuccio, F. P. (2013) · BMJ · doi:10.1136/bmj.f1378 · Cited by 938
Self-citationSodium and Potassium in the Pathogenesis of Hypertension
Adrogué, H. J., & Madias, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064486 · Cited by 763
Huang, L., Trieu, K., Yoshimura, S., Neal, B., Woodward, M., Campbell, N. R. C., Li, Q., Lackland, D. T., Leung, A. A., Anderson, C. A. M., et al. (2020) · BMJ · doi:10.1136/bmj.m315 · Cited by 403
Self-citationCobb, L. K., Anderson, C. A. M., Elliott, P., Hu, F. B., Liu, K., Neaton, J. D., Whelton, P. K., Woodward, M., & Appel, L. J. (2014) · Circulation · doi:10.1161/cir.0000000000000015 · Cited by 300
Self-citationPotassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
Filippini, T., Naska, A., Kasdagli, M., Torres, D., Lopes, C., Carvalho, C., Moreira, P., Malavolti, M., Orsini, N., Whelton, P. K., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015719 · Cited by 271
A Systematic Review of the Sources of Dietary Salt Around the World
Bhat, S., Marklund, M., Henry, M. E., Appel, L. J., Croft, K. D., Neal, B., & Wu, J. H. Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz134 · Cited by 221
Self-citation
Cited by
Items 201–300 of 742
Egan, B. M., Lackland, D. T., Sutherland, S. E., Rakotz, M., Williams, J., Commodore-Mensah, Y. Y., Jones, D. W., Kjeldsen, S. E., Campbell, N. R. C., Parati, G., et al. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-00990-1 · Cited by 15
“The combined bene fi ts of reducing sodium and increasing potassium intake include lowering SBP ~4 – 6 mmHg and CVD mortality approximately 10% [41, 42].”
InfluentialSettling the controversy of salt substitutes and stroke: sodium reduction or potassium increase?
Messerli, F. H., O'Donnell, M. J., Mente, A., & Yusuf, S. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac160 · Cited by 13
de la SEC, G. D. T. D. L. S. P. L. G. E. 2. S. L. P. D. L. E. C. E. L. P. C. Y. C. D. G. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.015 · Cited by 12
Village doctors managing hypertension in rural China
Jafar, T. H., & Jabbour, S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00424-x · Cited by 14
Crouch, S. H., Ware, L. J., Norris, S. A., & Schutte, A. E. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.12.015 · Cited by 14
Sodium – a systematic review for Nordic Nutrition Recommendations 2023
Jula, A. (2024) · Food & Nutrition Research · doi:10.29219/fnr.v68.10319 · Cited by 19
“A recent cluster-RCT involving 20,995 persons from 600 villages in rural China studied the effect of potassium enriched salt substitute on CVD (81).”
BackgroundJiang, L., Shen, W., Wang, A., Fang, H., Wang, Q., Li, H., Liu, S., Shen, Y., & Liu, A. (2024) · Nutrients · doi:10.3390/nu16091307 · Cited by 13
“Limiting daily sodium intake can effectively lower the risk of elevated blood pressure and subsequent CVD, while HSI may have the opposite effect through pathways including stiffened endothelial cells, thickened resistance arteries, and blocked nitric oxide synthesis [11,12].”
BackgroundMotiejūnaitė, J., Flamant, M., Arnoult, F., Lahens, A., Tabibzadeh, N., Boutten, A., Rouzet, F., Vrtovsnik, F., Vidal‐Petiot, E., & de Pinho, N. A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01778-5 · Cited by 14
Zhang, X., Ye, W., Xin, X.-K., Gao, Y., & Yang, F. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1437633 · Cited by 15
Self-citationWu, S., Wang, Y., Wang, J., Feng, J. H., Li, F., Lin, L., Ruan, C., Nie, Z., Tian, J., & Jin, C. (2025) · BMC Medicine · doi:10.1186/s12916-025-03923-4 · Cited by 17
“Since sodium restriction is the most common dietary recommendation for preventing hypertension and reducing BP, and current guidelines advise reducing sodium intake [4, 12, 28], we chose salt consumption to assess diet health.”
Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure
Kao, T., & Huang, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1086672 · Cited by 14
Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease
Jones, D. W., Clark, D., Morgan, T. O., & He, F. J. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19248 · Cited by 12
Satoh, M., Nakayama, S., Nobayashi, H., Iwabe, Y., Izumi, S., Murakami, T., Hirose, T., & Metoki, H. (2026) · Hypertension Research · doi:10.1038/s41440-025-02532-1 · Cited by 17
Kittleson, M. D., Panjrath, G. S., Bates, K., Breathett, K. K., Dixon, D. L., Januzzi, J. L., & Mohammed, S. F. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.06.018 · Cited by 25
Mu, L., Zou, Y., Tang, J. T., Zhang, F., Chen, D., Lisha, M., Xu, H., Yu, P., Ren, Y., & Mei, Y. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04622 · Cited by 13
Gritter, M., Wei, K., Wouda, R. D., Musterd‐Bhaggoe, U. M., Dijkstra, K. L., Kers, J., Ramakers, C. R. B., Vogt, L., de Borst, M. H., Danser, A. H. J., et al. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad220 · Cited by 13
“Increasing K + intake through K + supplementation or salt substitution decreases blood pressure and improves cardiovascular outcomes [5 , 8 ].”
BackgroundConsensus document on the management of hyperkalemia
Ortíz, A., del Arco, C., Fernández‐García, J. C., Cerezo, J. G., Ochoa, R. I., Núñez, J. E., Gutiérrez, F. P., & Navarro‐González, J. F. (2023) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2023.12.002 · Cited by 14
Formulation of novel low-sodium salts using potassium salts and dietary polysaccharide
Lu, W. J., Hu, Z., Chen, H., Wu, J., & Fang, Y. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114934 · Cited by 11
Kidney-specific WNK1 amplifies kidney tubule responsiveness to potassium via WNK body condensates
Boyd‐Shiwarski, C. R., Beacham, R. T., Lashway, J., Querry, K. E., Griffiths, S. E., Shiwarski, D. J., Knoell, S. A., Nguyen, N. H., Nkashama, L. J., Valladares, M. N., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188792 · Cited by 16
New Trends in the Diagnosis and Management of Hypertension
Tinawi, M. (2022) · Cureus · doi:10.7759/cureus.22393 · Cited by 14
“enrolled approximately 21,000 subjects from rural china [40].”
BackgroundLi, Z., Xie, S., Sun, B., Zhang, Y., Liu, K., & Liu, L. (2022) · Journal of Food Processing and Preservation · doi:10.1111/jfpp.16622 · Cited by 11
Self-citationSkin regulation of salt and blood pressure and potential clinical implications
Martin, K., Toussaint, N. D., Tan, S., & Hewitson, T. D. (2022) · Hypertension Research · doi:10.1038/s41440-022-01096-8 · Cited by 11
“trolled study demonstrated that salt substitutes with potassium chloride significantly reduce cardiovascular events, stroke and mortality [79].”
BackgroundLifetime home BP-centered approach is the core from onset to aggravation of hypertension
Kario, K., Hoshide, S., & Mogi, M. (2023) · Hypertension Research · doi:10.1038/s41440-023-01174-5 · Cited by 13
“regular salt (100% sodium chloride), in community-dwelling persons who had a history of stroke or were 60 years of age or older and had high BP, the rates of stroke, major cardiovascular events, and death from any cause were lower with the salt substitute than with regular salt [31].”
BackgroundSmyth, A., Judge, C. S., Kerins, C., McDermott, S., Niland, A., Corcoran, C., Dineen, R., Alvarez‐Iglesias, A., Nolan, A. M., Mente, A., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101856 · Cited by 11
Integrated Omic Analysis of Human Plasma Metabolites and Microbiota in a Hypertension Cohort
Chen, B., Li, Y., Lin, W.-Z., Bi, C., Du, L., Liu, Y., Zhou, L.-J., Liu, T., Xu, S., Zhang, J., et al. (2023) · Nutrients · doi:10.3390/nu15092074 · Cited by 12
Self-citationWouda, R. D., Gritter, M., Karsten, M., Michels, E. H. A., Nieuweboer, T. M., Danser, A. H. J., de Borst, M. H., Hoorn, E. J., Rotmans, J. I., & Vogt, L. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000228 · Cited by 12
Dietary management of dyslipidemia
Chopra, A. K. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.12.005 · Cited by 15
Using Genetics to Inform Interventions Related to Sodium and Potassium in Hypertension
Reay, W. R., Clarke, E. D., Eslick, S., Riveros, C., Holliday, E. G., McEvoy, M., Peel, R., Hancock, S., Scott, R. J., Attia, J., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.065394 · Cited by 12
“8 There is a large body of evidence showing that adjusting an individual’s ratio of sodium to potassium intake can influence BP, 9–12 with specific recommendations that the ideal ratio of sodium to potassium is 1:1 or lower.”
Okuda, N., Higashiyama, A., Tanno, K., Yonekura, Y., Miura, M., Kuno, H., Nakajima, T., Nagahata, T., Taniguchi, H., Kosami, K., et al. (2024) · Nutrients · doi:10.3390/nu16101433 · Cited by 9
“However, the participants of these studies have been limited to older and high-risk individuals, namely residents of senior care facilities [25], poorly controlled hypertensive persons, or those with a history of stroke [26].”
BackgroundMethodAminde, L. N., Nugraheni, W. P., Mubasyiroh, R., Rachmawati, T., Dwirahmadi, F., Martini, S., Kusumawardani, N., & Veerman, L. J. (2024) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2024.100432 · Cited by 14
The Guidelines for use and promotion of low sodium salt in China
Yuan, Y., Gao, C., Yin, X., Zhang, X., Ji, Y., Zheng, X., Zhou, Q. X., & Wu, Y. (2024) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12621 · Cited by 10
“22,23,28 The meta-analysis of a total of 17,311 participants from the three studies showed that low sodium salts significantly reduced SBP 4.1 (95% CI: − 5.6, − 2.6) mmHg (Figure S16).”
BackgroundInfluentialSelf-citationTransient High Salt Intake Promotes T-Cell–Mediated Hypertensive Vascular Injury
Yakoub, M., Rahman, M., Kleimann, P., Hoffe, J., Feige, M., Bouvain, P., Alter, C., Kluczny, J. I., Reidel, S., Nederlof, R., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23115 · Cited by 11
“21 Recent data have shown that salt not only increases BP but also shifts immune responses to a proinflammatory phenotype.”
Nutrition and Hypertension Researches in 2023: focus on salt intake and blood pressure
Matsumoto, C. (2025) · Hypertension Research · doi:10.1038/s41440-024-02089-5 · Cited by 18
“Regarding the cost-effectiveness of salt substitutes, the Salt Substitute and Stroke Study (SSaSS) provided evidence that salt substitutes are both effective and cost-saving in reducing the risk of major CVD events and all-cause mortality among individuals at high CVD risk [31, 32].”
Unlocking health equity by eliminating copayments for essential antihypertensive medications
Frieden, T. R., Garg, R., Banigbe, B., Choudhury, S. R., Ogbureke, N., Duguma, D., & Tangcharoensathien, V. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103094 · Cited by 11
Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions
Dalakoti, M., Lin, N. H. Y., Yap, J. J. L., Cader, F. A., Prajapati, D., Lee, D. P. H., Shariff, R. E. R., Cuenza, L. R., Honda, S., Malis, V., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101676 · Cited by 15
Managing Hypertension in Chronic Kidney Disease: The Role of Diet and Guideline Recommendations
Stambolliu, E., Iliakis, P., Tsioufis, K. P., & Damianaki, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113755 · Cited by 15
“…practical recommendations for the general population, such as the use of salt substitutes (which often contain KCL), have been shown to reduce BP and lower CV risk [54–56], their use in advanced CKD or patients using a potassium-sparing diuretic raises concerns about elevated potassium levels.”
Relationship Between Salt Intake and Cardiovascular Disease
Han, F., Li, W., Duan, N., Hu, X., Yao, N., Yu, G., & Qu, J. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70078 · Cited by 18
Sodium, Potassium and Iodine Intake in an Adult Population of Lithuania
Žakauskienė, U., Mačionienė, E., Zabulienė, L., Sukackienė, D., Linkeviciute-Dumce, A., Banys, V., Bratčikovienė, N., Karosiene, D., Slekiene, V., Kontrimas, V., et al. (2022) · Nutrients · doi:10.3390/nu14183817 · Cited by 12
“A recent study has shown that replacing conventional (sodium) salt with potassium-enriched salt significantly reduced the incidence of cardiovascular disease and deaths in a large high-risk Chinese population [43].”
BackgroundBanzrai, C., Bosookhuu, O., Yadamsuren, E., Dambasuren, B., Turbat, S., Erdenedalai, T., Myadagsuren, M., Munkhtur, U., Baatar, K., Boldbayar, P., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00130-4 · Cited by 13
Structuring meat analogs by citrus fiber with reduced salt intake
Li, Y., Qian, C., Guo, J., Wang, J., & Yang, X. (2023) · Journal of Food Science · doi:10.1111/1750-3841.16690 · Cited by 12
National Initiatives on Salt Substitutes: Scoping Review
Kong, B., Yang, S., Long, J., Tang, Y., Liu, Y., Ge, Z., Rong, S., Wu, Y., Ding, G., Yang, Y., et al. (2023) · JMIR Public Health and Surveillance · doi:10.2196/45266 · Cited by 10
“…controlled trial in a Chinese population of >20,000 older people from 600 villages with a history of stroke or hypertension demonstrated that salt substitutes significantly reduced the risk of stroke, major cardiovascular events, and death (rate ratios=0.86, 0.87, and 0.88, respectively) [73].”
InfluentialSelf-citationDietary salt intake in chronic kidney disease. Recent studies and their practical implications
O’Callaghan, C. A. (2024) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16715 · Cited by 16
Eurasian clinical practice guidelines for dietary management of cardiovascular diseases (2024)
Starodubova, A. V., Chazova, I. E., Tutelyan, V. A., Nikityuk, D. B., Pavlovskaya, E. V., Кislyak, O. A., Blinova, N. V., Brumberg, A. A. B., Bubnova, M. G., Varaeva, Y. R., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-4-6-66 · Cited by 13
Sadki, D., Fawaz, S., Liegey, J.-S., Pucheu, Y., Boulestreau, R., Beuque, G., Foucher, J., Hein, L., & Couffinhal, T. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf020 · Cited by 10
Granal, M., Sourd, V., Burnier, M., Fauvel, J., & Gougeon, A. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf173 · Cited by 22
Updates in the 2025 AHA/ACC Hypertension Guideline
Brown, C. A., Clark, D., & Jones, D. W. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01372-9 · Cited by 13
Christa, M., Hahner, S., Köstler, H., Bauer, W. R., Störk, S., & Weng, A. M. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0074 · Cited by 9
Karlsson, K., Rådholm, K., Dunford, E., Wu, J. H. Y., Neal, B. C., & Sundström, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1182132 · Cited by 10
“Reducing sodium intake has recently been convincingly demonstrated to reduce the risk of CVDs and mortality (6).”
BackgroundSelf-citationZhang, Z., Zhou, X., Mei, Y., Bu, X., Tang, J. T., Gong, T., Liu, G., Cai, S., Ren, Y., & Mu, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1219381 · Cited by 14
“A 5-year trial in China confirmed the health benefits and safety of low-sodium salt; however, the trial did not assess blood potassium markers, and it was unclear whether hyperkalemia could be a consequence (10).”
Salt substitution: opportunities and challenges for nephrology
Hoorn, E. J., Marklund, M., & Wu, J. H. Y. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00599-4 · Cited by 9
The Highs and Lows of Potassium Intake in CKD—Does One Size Fit All?
Terker, A. S., Saritas, T., & McDonough, A. A. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022070743 · Cited by 9
Salt and Aldosterone – Reciprocal and Combined Effects in Preclinical Models and Humans
Chen, L., Adolf, C., Reincke, M., & Schneider, H. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2172-7228 · Cited by 10
“Salt substitution to replace sodium with potassium as done in the SSaSS study [82] might be an amenable new therapeutic strategy to facilitate the adoption of a diet lower in sodium.”
BackgroundPotassium-Alkali–Enriched Diet, Hypertension, and Proteinuria following Uninephrectomy
Ralph, D. L., Ha, D., Lei, H., Priver, T. S., Smith, S. D., McFarlin, B. E., Schwindt, S., Pandya, D., Koepsell, H., Pastor‐Soler, N. M., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000420 · Cited by 9
“…two goals in unineph-rectomized rats: ( 1 ) Test how a K 1 -alkali – enriched, low-Na 1 diet (HK-alk), components associated with kidney health, 15 – 18 affects post-uninephrectomy hypertension and renal ion transporter abundance compared with a conventional 2% NaCl-enriched, K 1 -poor diet…”
Ouyang, W., Xiao, B.-J., Chen, H., Fu, L., Tang, F., Marrone, G., Liu, X., Wu, Y., & Carrero, J. J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1547181 · Cited by 11
Self-citationThe clinical significance of T-cell regulation in hypertension treatment
Fu, M., Lv, M., Guo, J., Mei, A., Qian, H., Yang, H., Wu, W., Liu, Z., Zhong, J., Wei, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550206 · Cited by 14
Cui, J.-M., Xu, Z.-W., Dai, Y., Wang, Q., Hou, Z.-H., Zhang, Y.-C., & Jia, H.-L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1513981 · Cited by 8
Self-citationLowering Sodium Intake: Reduction and Substitution for Cardiovascular Health
Hu, N., & McLean, R. M. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr36289 · Cited by 12
The role of immune mechanisms in hypertension and advances in immunomodulatory research
Chen, X., Sun, L., Xuan, K., & Zong, A. (2025) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2025.2535328 · Cited by 11
“Salt indeed plays a fundamental role in the development of hypertension and its related diseases (30,37).”
Assmus, A. M., Odgaard, L. N., Garrelds, I. M., Danser, A. H. J., Matchkov, V. V., Welling, P. A., & Fenton, R. A. (2025) · Communications Biology · doi:10.1038/s42003-025-08976-y · Cited by 9
“A high dietary salt (Na + ) intake has consistently been demonstrated to increase BP at the population level 1,13,17 .”
InfluentialRichards, L. G., Ifejika, N. L., Stein, J., Bahouth, M. N., Saylor, M. A., Barrett, A. M., Chen, P., Deutsch, A. F., Dusenbury, W., Ellis, C., et al. (2026) · Stroke · doi:10.1161/str.0000000000000536 · Cited by 13
A New Understanding of Potassium's Influence Upon Human Health and Renal Physiology
McCormick, J. A., Topf, J. M., Tomacruz, I. D. V., & Grimm, P. R. (2023) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2023.01.001 · Cited by 9
Bae, C. J., Zee, P. C., Leary, E. B., Fuller, D. S., Macfadden, W., Candler, S. A., Steininger, T. L., & Husain, A. M. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.05.023 · Cited by 9
Need for a nutrition-specific scientific paradigm for research quality improvement
Flanagan, A., Bradfield, J., Kohlmeier, M., & Ray, S. (2023) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2023-000650 · Cited by 9
“27 Prior to the publication of SSaSS, the best available evidence for the effects of salt reduction on CVD event end points was derived from a meta-analysis of RCTs with a total of 1615 and 1610 participants in the intervention and control groups, respectively, which demonstrated a 20% (RR 0.80,…”
MethodInfluentialSun, H., Zhou, Y., Jiang, S., Zhao, D., Li, H., Lu, Y., Ma, B., & Zhou, B. (2023) · Food & Function · doi:10.1039/d3fo02393a · Cited by 8
Self-citationYu, J., Arnott, C. G., Li, Q., Tanna, G. L. D., Tian, M., Huang, L., Yin, X., Zhang, X., Pearson, S., Labarthe, D. R., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22410 · Cited by 9
“7 By contrast, individuals with hypokalaemia were not excluded from the trial and it is possible that potassium supplementation achieved with the potassium-enriched salt could have provided protection against cardiac arrhythmia among people with low potassium levels.”
BackgroundSelf-citationRole of dietary potassium and salt substitution in the prevention and management of hypertension
Chia, Y. C., He, F. J., Cheng, M.-H., Shin, J., Cheng, H.-M., Sukonthasarn, A., Wang, T., Huynh, M. V., Buranakitjaroen, P., Sison, J., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01862-w · Cited by 10
“…events (49.09 events vs. 56.29 events per 1000 person-years; rate ratio, 0.87; 95% CI, 0.80 – 0.94; p < 0.001) and death (39.28 events vs. 44.61 events per 1000 person-years; rate ratio, 0.88; 95% CI, 0.82 – 0.95; p < 0.001) were also all signi fi cantly lower in the salt sub-stitute group [72].”
InfluentialPan‐risk factor for a comprehensive cardiovascular health management
Zheng, R., Xu, Y., Li, M., Lu, J., Xu, M., Wang, T., Zhao, Z., Wang, S., Lin, H., Zhang, X., et al. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13258 · Cited by 9
“74 years of follow-up, the rates of stroke, major cardiovascular events, and death from any cause were lower with the salt substitute than with regular salt.(44) Vitamin D deficiency is a marker of increased cardiovascular risk related to cardiovascular events.”
BackgroundSelf-citationKang, E., Prager, O., Lublinsky, S., Oliveira-Ferreira, A. I., Reiffurth, C., Major, S., Müller, D. N., Friedman, A., & Dreier, J. P. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221135085 · Cited by 8
“Saltsensitivity is usually defined as a significant blood pressure response to increased NaCl intake,(42) whereas KCl intake lowers blood pressure.(92,93) The Naþ sensor(s) that mediate this pressure response have not been fully elucidated.”
BackgroundProtect the Kidneys and Save the Heart Using the Concept of Food as Medicine
Cardozo, L., Borges, N. A., Ribeiro, M. M., Wang, A. Y.-M., & Mafra, D. (2023) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2023.08.002 · Cited by 12
Meng, D., Cobb, L. K., Ide, N., & Ge, Z. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14741 · Cited by 8
Highlights in ASCVD Primary Prevention for 2021
Polonsky, T. S., Khera, A., Miedema, M. D., Schocken, D. D., & Wilson, P. W. F. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.025973 · Cited by 9
The potential scalability of salt substitutes as an intervention to lower population sodium levels
Bernabé‐Ortiz, A., Trieu, K., Markland, M., Wu, J. H. Y., Saavedra‐Garcia, L., Hart, A. C., Yu, J., Thout, S. R., Miranda, J. J., & Webster, J. L. (2022) · Salud Pública de México · doi:10.21149/12788 · Cited by 9
Self-citationThe sodium hidden in medication: a tough pill to swallow
Schutte, A. E., & Neal, B. C. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab888 · Cited by 8
Self-citationPost-Ganglionic Sympathetic Neurons can Directly Sense Raised Extracellular Na+ via SCN7a/Nax
Davis, H., Paterson, D. J., & Herring, N. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.931094 · Cited by 7
Guan, Y., Qi, Y.-M., Zheng, L., Yang, J., Zhang, M., Zhang, Q., & Ji, L. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068127 · Cited by 7
Salt reduction in cured meat products: a review on strategies and mechanisms
Chen, Q., Cao, J., She, W., Bai, W., Zeng, X., & Dong, H. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250056 · Cited by 7
Revisiting resistant hypertension in kidney disease
Bansal, S. (2024) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001002 · Cited by 14
Hongling, C., Yishu, L., Yang, W., Tian, M., Zhenhua, Y., Lin, Z., Nan, L., Yangfeng, W., Zhao, Y., Chunhua, C., et al. (2025) · Chinese general practice journal. · doi:10.1016/j.cgpj.2025.100070 · Cited by 7
Self-citationLai, H., NESRALLAH, G. E., Guyatt, G. H., Vernooij, R. W. M., Liu, J., Zhao, W., Hou, L., Pan, B., Huang, J., Campbell, N. R. C., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04635-z · Cited by 9
“The mortality benefits of moderate-potassium and low-sodium salt substitutes were primarily supported by a large Chinese RCT ( n = 20,995 participants) [61].”
Sun, X.-S., Zhu, M., Wen, D., Luo, D., Sun, R., Chen, Q., & Mai, H. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.01.026 · Cited by 7
Arterial hypertension - clinical trials update 2022
Götzinger, F., Kunz, M., Lauder, L., Böhm, M., & Mahfoud, F. (2022) · Hypertension Research · doi:10.1038/s41440-022-00931-2 · Cited by 9
“regular salt containing 100% sodium chloride) reduces the incidence of stroke and cardiovascular disease [7].”
BackgroundRegulation of Distal Nephron Transport by Intracellular Chloride and Potassium
Rodan, A. R. (2022) · The Nephron journals/Nephron journals · doi:10.1159/000526051 · Cited by 7
O’Callaghan, C. A., Camidge, C., Thomas, R., Reschen, M. E., Maycock, A. J., Lasserson, D. S., Fox, R. A., Thomas, N. P. B., Shine, B. S. F., & James, T. J. (2023) · Kidney360 · doi:10.34067/kid.0000000000000160 · Cited by 9
“A recent study of cluster-randomized rural villages in China used a salt substitute (75% sodium chloride and 25% potassium chloride) or normal salt, and showed a reduction in stroke, major cardiovascular events, and death in people with a history of stroke or who were older than 60 years with high BP. 29 This study de…”
BackgroundDiet to Stop Hypertension: Should Fats be Included?
Nestel, P. J., & Mori, T. A. (2024) · Current Hypertension Reports · doi:10.1007/s11906-024-01310-7 · Cited by 10
“An open-label study in 20,995 Chinese participants among whom 88.4% were hypertensive was conducted in villages over 4.74 years comparing a salt substitute (75% sodium chloride and 25% potassium chloride) with their usual diet [14].”
BackgroundInfluentialPandian, J. D., Sylaja, P. N., Lackland, D. T., Babu, V., Paramasivan, N. K., Sebastian, I. A., Parati, G., Anderson, C. S., Ovbiagele, B. I., Fisher, M., et al. (2024) · International Journal of Stroke · doi:10.1177/17474930241309276 · Cited by 10
“25 Physical activity is inversely associated with BP and CVD events, including stroke.”
Cheng, C., Liao, H., Peng, K., Chen, T.-H., Lin, Y., Chueh, S., Wu, V., & on behalf of the TAIPAI Study Group (2021) · Biomedicines · doi:10.3390/biomedicines9121816 · Cited by 8
Xiao, H., Lu, H., Xue, Y., Jia, Z., Dai, M., He, K., & Zhao, R. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.10.010 · Cited by 7
Lazo‐Porras, M., Valle, A. D., Beran, D., Pesantes, M. A., Pérez-León, S., Ponce-Lucero, V., Bernabé‐Ortiz, A., Cárdenas, M. K., Chappuis, F., Perel, P., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1068624 · Cited by 7
“Studies have found that salt substitution strategies improve blood pressure levels in people with hypertension (5, 6) and cardiovascular outcomes including mortality (7).”
BackgroundLin, C., Chung, C., Liao, N.-C., Chen, P., Chi, N., Lai, Y., Tang, C., Wu, C., Chang, F., Luo, C., et al. (2023) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000952 · Cited by 7
“89 With regards to other dietary patterns, a randomized trial of 7447 high-risk cardiovascular patients demonstrated that subjects on a Mediterranean diet (with nuts) with no specific calorie restriction had a lower risk of stroke when compared with subjects on a non-Mediterranean, low-fat diet…”
Ganbaatar, G., Okami, Y., Kadota, A., Ganbaatar, N., Yano, Y., Kondo, K., Harada, A., Okuda, N., Yoshita, K., Okamura, T., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64330 · Cited by 7
“Salt intake is an important risk factor for all-cause and CVD mortality 7) and is considered the main component of any diet.”
BackgroundSalt restriction for treatment of hypertension – current state and future directions
Nolan, P., & McEvoy, J. W. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001098 · Cited by 9
Prevalence and factors associated with masked hypertension in chronic kidney disease
Legrand, F., Motiejūnaitė, J., Arnoult, F., Lahens, A., Tabibzadeh, N., Robert, T., Rouzet, F., de Pinho, N. A., Vrtovsnik, F., Flamant, M., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003680 · Cited by 8
Prediction of 24‐Hour Urinary Sodium Excretion Using Machine‐Learning Algorithms
Hamaya, R., Wang, M., Juraschek, S. P., Mukamal, K. J., Manson, J. E., Tobias, D. K., Sun, Q., Curhan, G. C., Willett, W. C., Rimm, E. B., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034310 · Cited by 7
“…demonstrates sodium intake plays a causal role in the development of hypertension, observational studies with longer follow-up periods can provide additional insights, including contributions of other modifiable lifestyle factors to incident hypertension 7,8 or other chronic disease end points.”
Leal, P. E. D. P. T., da Silva, A. A., Rocha‐Gomes, A., Riul, T. R., Cunha, R. A., Reichetzeder, C., & Villela, D. C. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.779080 · Cited by 9
Physical activity and nutrition in chronic kidney disease
Wang, A. Y.-M., March, D. S., & Burton, J. O. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000947 · Cited by 9
McCarthy, M. J., O’Keeffe, L. M., Williamson, P. R., Sydes, M. R., Farrin, A. J., Lugg-Widger, F. V., Davies, G., AVERY, K. N. L., Chan, A., Kwakkenbos, L., et al. (2021) · HRB Open Research · doi:10.12688/hrbopenres.13314.1 · Cited by 5
“(1) Involvement of key stakeholders including trialists, trial funders, trial methodologists, guideline experts, regulators, TMRN and Trial Methodology Research Partnership (TMRP), ethics board members, and PPI contributors in the team that is developing the extension with an extended group being recruited for the Del…”
BackgroundChatterjee, R., Davenport, C. A., Fox, E. R., Vasan, R. S., & Mitchell, G. F. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.100955 · Cited by 6
“In sub-group analyses, there was a significantly reduced risk of stroke among those in the SSaSS trial without a prior history of stroke [45], suggesting that there are benefits to potassium supplementation for primary prevention of CVD. Based in large part on the results of the SSaSS trial, the…”
Miranda, J. J. (2025) · Global Heart · doi:10.5334/gh.1419 · Cited by 7
Zietara, A. P., Dissanayake, L. V., Lowe, M. E., Xu, B., Levchenko, V., Kain, V., Halade, G. V., Klemens, C. A., Palygin, O., & Staruschenko, A. (2025) · JCI Insight · doi:10.1172/jci.insight.181778 · Cited by 7
“Another study conducted in rural China observed that the substitution of sodium chloride with 75% sodium chloride and 25% potassium chloride significantly lowered the risk of stroke, major cardiovascular events, and death in people aged 60 years old or higher with high blood pressure (17).”
Saito, Y., Tateishi, K., Kato, K., Kitahara, H., & Kobayashi, Y. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5950-25 · Cited by 8
“Furthermore, the landmark SSaSS trial, an open-label, cluster-randomized trial involving persons from 600 villages in rural China, demonstrated fewer cardiovascular events in villages where participants used a salt substitute than in others without such intervention (25).”
Metadata
- Authors
- Neal, B., Wu, Y., Feng, X., Zhang, R., Zhang, Y., Shi, J., Zhang, J., Tian, M., Huang, L., Li, Z., Yu, Y., Zhao, Y., Zhou, B., Sun, J., Liu, Y., Yin, X., Hao, Z., Yu, J., Li, K.-C., Zhang, X., Duan, P., Wang, F., Ma, B., Shi, W., Di Tanna, G. L., Stepien, S., Shan, S., Pearson, S.-A., Li, N., Yan, L. L., Labarthe, D., & Elliott, P.
- Affiliations
- The George Institute for Global Health (GB)
- Harbin Medical University (CN)
- From the George Institute for Global Health (B.N., M.T., L.H., Y.L., X.Y., J.Y., K.-C.L., G.L.D.T., S. Stepien, S. Shan) and the Centre for Big Data Research in Health (S.-A.P.), University of New South Wales, and George Clinical (N.L.) — all in Sydney; the School of Public Health (B.N., K.-C.L., P.E.), the U.K. Dementia Research Institute (P.E.), the British Heart Foundation Centre for Research Excellence (P.E.), and the NIHR Imperial Biomedical Research Centre (P.E.), Imperial College London, Health Data Research (P.E.), the NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards (P.E.), and the Medical Research Council Centre for Environment and Health (P.E.) — all in London; Peking University Clinical Research Center, Peking University (Y.W.), the George Institute for Global Health at Peking University Health Science Center (Y.W., M.T., Z.H., X.Z., L.L.Y.), and the Department of Cardiology, Peking University Third Hospital (J.Y.), Beijing, the School of Public Health, Changzh...
- Northwestern University (US)
- ORCID
- Neal, Bruce
- Wu, Yangfeng
- Zhang, Ruijuan
- Zhang, Yuhong
- Shi, Jingpu
- Zhang, Jianxin
- Tian, Maoyi
- Huang, Liping
- Li, Zhifang
- Yu, Yan
- Zhao, Yi
- Zhou, Bo
- Liu, Yishu
- Yin, Xuejun
- Yu, Jie
- Zhang, Xinyi
- Duan, Peifen
- Wang, Faxuan
- Ma, Bing
- Shi, Weiwei
- Stepien, Sandrine
- Shan, Sana
- Pearson, Sallie-Anne
- Li, Nicole
- Yan, Lijing L.
- Labarthe, Darwin
- Elliott, Paul
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-16
- Volume
- 385
- Issue
- 12
- Pages
- 1067-1077
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198627281
- Cited by
- 742
- References
- 21
- Citations by year
- 2026: 119 · 2025: 165 · 2024: 131 · 2023: 168 · 2022: 133 · 2021: 24
- FWCI
- 72.81
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Health and Medical Research Council (APP1049417, APP1164206)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- salt substitutes, potassium chloride, sodium chloride, hypertension, stroke prevention, major adverse cardiovascular events, mortality, hyperkalemia, blood pressure, older adults, rural China, dietary salt reduction, secondary stroke prevention, cost-effectiveness
- MeSH terms
- Aged, Cardiovascular Diseases, China, Diet, Sodium-Restricted, Female, Humans, Hyperkalemia, Hypertension, Male, Middle Aged, Mortality, Potassium, Dietary, Stroke, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.